THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
发明人:
申请号：
EP10716433.7
公开号：
EP2411521B1
申请日:
2010.03.25
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
Embodiments of the invention are directed to methods of treating, inhibiting or attenuating a microbial infection in an individual who has or is at risk for developing such an infection, comprising the step of administering an effective amount of a TLR9 agonist and a TLR 2/6 agonist to the individual.
